NUFLOR PIG PREMIX

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

FLORFENICOL

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

florfenicol(40g/kg)

Pharmaceutical form:

ORAL POWDER, PRE-MIX

Composition:

FLORFENICOL ANTIBIOTIC Active 40.0 g/kg

Units in package:

25 kg; 5 kg

Class:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

Therapeutic group:

PIGS | BOAR | GILT | PIGLET | SOW | SWINE

Therapeutic area:

ANTIBIOTIC & RELATED

Therapeutic indications:

ACTINOBACILLUS PLEUROPNEUMONIAE (HAEMOPH | MYCOPLASMA SPP. | PASTEURELLA MULTOCIDA | RESPIRATORY DISEASE | STREPTOCOCCUS SUIS TYPE 2 | FOWL CHOLERA

Product summary:

Poison schedule: 4; Withholding period: MEAT: REMOVE ALL MEDICATED FEED 12 days before slaughter for human consumption. Any variation by the prescribing veter inarian to the approved dose, frequency, duration, route, disease or target spec ies may require extending the approved w ithholding period. DO NOT USE less th an 15 days before slaughter for export. Before using this product, confirm the c urrent ESI from MSD Animal Health on 180 0 033 461 or the APVMA website (www.apvm a.gov.au/residues).; Host/pest details: PIGS: [ACTINOBACILLUS PLEUROPNEUMONIAE (HAEMOPH, MYCOPLASMA SPP., PASTEURELLA MULTOCIDA, RESPIRATORY DISEASE, STREPTOCOCCUS SUIS TYPE 2]; Poison schedule: 4; Withholding period: WHP: MEAT: REMOVE ALL MEDICATED FEED 12 days before slaughter for human cons umption. EXPORT SLAUGHTER INTERVAL (ESI ): DO NOT USE less than 15 days before slaughter for export.; Host/pest details: PIGS: [ACTINOBACILLUS PLEUROPNEUMONIAE (HAEMOPH, MYCOPLASMA SPP., PASTEURELLA MULTOCIDA, RESPIRATORY DISEASE, STREPTOCOCCUS SUIS TYPE 2]; Poison schedule: 4; Withholding period: ; Host/pest details: PIGS: [ACTINOBACILLUS PLEUROPNEUMONIAE (HAEMOPH, MYCOPLASMA SPP., PASTEURELLA MULTOCIDA, RESPIRATORY DISEASE, STREPTOCOCCUS SUIS TYPE 2]; For use in the treatment of pig respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multicoda, Mycoplasma spp. and Streptococcus suis Type 2.Contra-indicated for use in pigs intended for breeding. Restraints - USE ONLY in pigs for treatment of respiratory infections.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

PRODUCT NAME: NUFLOR PIG PREMIX
PAGE 1 OF 3
PACK SIZES: 5KG , 25KG
DATE: 03/12/2010 VERSION 2
DESCRIPTION: FRONT LABEL
APVMA: 60369/51320
PANEL LABELS, TEXT ABOVE THE HEADER AND BELOW THE FOOTER ARE NOT
INCLUDED IN THIS LABEL TEXT.
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
FOR ANIMAL TREATMENT ONLY
NUFLOR® PIG PREMIX
ACTIVE CONSTITUENTS:
FLORFENICOL 40 g/kg
_ _
For the treatment of pig respiratory disease associated with
_Actinobacillus pleuropneumoniae, _
_Pasteurella multocida, Mycoplasma_
spp. and
_Streptococcus suis_
Type 2.
5 kg [25 kg]
[MSD logo] RLP APPROVED
Infopest
Verified
PRODUCT NAME: NUFLOR PIG PREMIX
PAGE 2 OF 3
PACK SIZES: 5KG, 25KG
DATE: 03/12/2010
DESCRIPTION: BACK LABEL
APVMA: 60369/51320 V2
PANEL LABELS, TEXT ABOVE THE HEADER AND BELOW THE FOOTER ARE NOT
INCLUDED IN THIS LABEL TEXT.
NUFLOR
® PIG PREMIX
Florfenicol, the active ingredient in NUFLOR Pig Premix, is a
synthetic, broad spectrum
antibiotic active against many gram-negative and gram-positive
bacteria isolated from domestic
animals. Florfenicol acts by inhibiting bacterial protein synthesis at
the ribosomal level.
INDICATIONS
NUFLOR Pig Premix is indicated for use in the treatment of pig
respiratory disease associated
with
_Actinobacillus _
_pleuropneumoniae_
,
_Pasteurella _
_multocida_
,
_Mycoplasma_
spp.
and
_Streptococcus suis_
Type 2.
DIRECTIONS FOR USE:
RESTRAINTS
USE ONLY IN PIGS FOR TREATMENT OF RESPIRATORY INFECTIONS.
CONTRA-INDICATIONS
THIS PRODUCT IS CONTRA-INDICATED FOR USE IN PIGS INTENDED FOR
BREEDING.
ANY VARIATION BY THE PRESCRIBING VETERINARIAN TO THE APPROVED DOSE,
FREQUENCY, DURATION,
ROUTE, DISEASE OR TARGET SPECIES MAY REQUIRE EXTENDING THE APPROVED
WITHHOLDING PERIOD.
SIDE EFFECTS
Perianal inflammation may occur transiently in pigs following
treatment.
DOSAGE AND ADMINISTRATION
10 mg florfenicol / kg bodyweight / day for 5 days.
MIX THOROUGHLY IN FEED BEFORE USE. USE ALL PRODUCT WITHIN 3
MONTHS OF OPENING.
To treat pigs eating 5% of their bodyweight at

Summary of Product characteristics

PRODUCT NAME: NUFLOR PIG PREMIX
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JANUARY, 2010
PAGE: 1 OF 6
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
CHEMICAL NATURE:
Florfenicol, is a broad-spectrum antibiotic and is presented in a
calcium carbonate carrier.
TRADE NAME:
NUFLOR PIG PREMIX
RECOMMENDED USE:
For the treatment of certain pig respiratory diseases as listed on the
product label.
APVMA NO:
60639
CREATION DATE:
January, 2010
THIS VERSION ISSUED:
January, 2010
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Xn, Harmful. N, Dangerous to the environment. Not classified as
hazardous
according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
R52/53. Harmful to aquatic organisms, may cause long-term adverse
effects to the aquatic
environment.
SAFETY PHRASES:
S22, S25, S29, S57. Do not breathe dust. Avoid contact with eyes. Do
not empty into drains. Use
appropriate container to avoid environmental contamination.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
White powdered solid.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. This is
an antibiotic preparation.
Any person with a history of allergies to this class of substances
should avoid all contact with this product as it may cause
sensitisation. This is a physiologically active product and so contact
should be minimised, especially if the user is taking a
form of medication, as interactions can sometimes give unexpected and
undesired results.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than m